Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing To Advance Enzymatic Dna Synthesis Toward Initial Commercial Access
Apr 15, 2021•over 4 years ago
Amount Raised
$24 Million
Round Type
series a
Description
Molecular Assemblies, Inc., today announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures. In addition LYFE Capital has joined the syndicate. The proceeds of the financing will be used to advance the company's proprietary enzymatic DNA synthesis technology toward early commercialization efforts.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech